SCHEMBL22657366

SCHEMBL22657366

CCCCSC(=S)SSC(=S)SCCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
ALDH1A1 P00352 3/20 0.39
ALDH2 P05091 1/20 0.39
LMNA P02545 3/20 0.35
HTT P42858 2/20 0.35
MGLL Q99685 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
ANPEP P15144 1/20 0.32
CES1 P23141 1/20 0.30
RECQL P46063 1/20 0.30
TSHR P16473 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22772238 0.92 NOS3 (0.39) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL20141621 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL22772241 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL16593899 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL21409858 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL22772272 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL22772256 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL21409776 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL22772273 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2
SCHEMBL2771539 0.90 MGLL (0.41) NOS3NOS1NOS2ALDH1A1ALDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4506373-A2 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION The Boeing Company (US) 2025-02-12 EP disclosed
EP-3969489-B1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION BOEING CO (US) 2024-12-25 EP disclosed
WO-2024043108-A1 PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED FILM, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-02-29 WO disclosed
WO-2024004619-A1 CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, FILM, OPTICAL ELEMENT, IMAGE SENSOR, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-01-04 WO disclosed
WO-2024004390-A1 CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, FILM, OPTICAL ELEMENT, IMAGE SENSOR, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-01-04 WO disclosed
WO-2024004426-A1 CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, FILM, OPTICAL ELEMENT, IMAGE SENSOR, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-01-04 WO disclosed
WO-2024004425-A1 CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, FILM, OPTICAL ELEMENT, IMAGE SENSOR, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-01-04 WO disclosed
US-20230286911-A1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE THE BOEING COMPANY 2023-09-14 US disclosed
US-20230286911-A1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE THE BOEING COMPANY 2023-09-14 US disclosed
US-20230286911-A1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE THE BOEING COMPANY 2023-09-14 US disclosed
US-11673858-B2 Polymer with upper critical solution temperature THE BOEING COMPANY (US) 2023-06-13 US disclosed
US-11673858-B2 Polymer with upper critical solution temperature THE BOEING COMPANY (US) 2023-06-13 US disclosed
US-11673858-B2 Polymer with upper critical solution temperature THE BOEING COMPANY (US) 2023-06-13 US disclosed
EP-3969489-A1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION The Boeing Company (US) 2022-03-23 EP disclosed
CN-113825776-A Polymers having an upper critical solution temperature in aqueous solution 波音公司 2021-12-21 CN disclosed
US-20200392344-A1 PHOTOSENSITIVE COMPOSITION FUJIFILM CORPORATION (JP) 2020-12-17 US disclosed
US-20200361859-A1 Polymer with upper critical solution temperature THE UNIVERSITY OF QUEENSLAND (AU) 2020-11-19 US disclosed
WO-2020231703-A1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION THE BOEING COMPANY (US) 2020-11-19 WO disclosed
US-20200361859-A1 Polymer with upper critical solution temperature THE UNIVERSITY OF QUEENSLAND (AU) 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361859-A1 Polymer with upper critical solution temperature MPST, ULK2, ULK3 NOS3 551/4885NOS1 277/4885NOS2 448/4885
US-11673858-B2 Polymer with upper critical solution temperature MPST, ULK2, ULK3 NOS3 551/4885NOS1 277/4885NOS2 448/4885
US-20230286911-A1 POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE MPST, ULK2, ULK3 NOS3 551/4885NOS1 277/4885NOS2 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.